Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome
- 24 January 2015
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 31 (4) , 535-544
Abstract
The importance of the central nervous system in cardiovascular events has been recognized. Recently, brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, is involved in depression mechanisms and also in stress and anxiety. Because BDNF is reported about cardioprotective role, we elucidated whether BDNF is associated with cardiovascular events in patients with chronic heart failure (CHF). We examined serum BDNF levels in 134 patients with CHF and 23 control subjects. The patients were followed to register cardiac events for a median of 426 days. BDNF was significantly lower in CHF patients than in control subjects (25.8 ± 8.4 vs 14.7 ± 8.4, P < 0.0001). Serum BDNF was also lower in patients with cardiac events than in event-free patients (16.1 ± 8.0 vs 12.5 ± 8.5, P < 0.0001). The cutoff value of BDNF was determined by performing receiver operating characteristic curve analysis. Kaplan–Meier analysis demonstrated that patients with low levels of BDNF experienced higher rates of cardiac events than those with high levels of BDNF. Multivariate Cox hazard analysis demonstrated that low BDNF levels (≤12.4 ng/mL) were an independent prognostic factor for cardiac events (hazard ratio 2.932, 95 % confidence interval 1.622–5.301; P = 0.0004). Adding levels of BDNF to the model with BNP levels, age, and eGFR for the prediction of cardiac events yielded significant net reclassification improvement of 0.429 (P < 0.001) and an integrated discrimination improvement of 0.101 (P < 0.001). Low serum BDNF levels were found in patients with CHF, and these levels were found to be independently associated with an increased risk of cardiac events.Keywords
This publication has 47 references indexed in Scilit:
- Serum BDNF levels before treatment predict SSRI response in depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- 8-Hydroxy-2′-deoxyguanosine is a prognostic mediator for cardiac eventEuropean Journal of Clinical Investigation, 2011
- Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-γ signaling for glutamate release via a glutamate transporterProceedings of the National Academy of Sciences, 2009
- Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the Brain-Derived Neurotrophic Factor (BDNF) GeneDiabetes, 2006
- Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromesInternational Journal of Cardiology, 2005
- Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failureJournal of Cardiac Failure, 2000
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogenThe Lancet, 1996
- Physiology of the NeurotrophinsAnnual Review of Neuroscience, 1996
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failureJACC, 1992